BIOMEDICA CROBIOMEDICA CRO
  • +38 (068) 150 70 04
  • office@biomedica-cro.com
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • ENEN
    • UAUA
Search
SEND REQUEST
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • Home
  • Blog
  • Biospecimen collection and Murphy’s First Law

Biospecimen collection and Murphy’s First Law

Biospecimen collection and Murphy’s First Law

29.11.2022
Biospecimen collection and Murphy's First Law
admin2024-05-29T14:30:25+00:00

What does Murphy’s First Law mean in the scientific world of preclinical studies and human biological sample collection? 

We live in a world where the right communication means everything. People around us are overloaded by gigabytes of information, so you need to be very precise to make them get you right. Murphy’s First Law says: anything that can go wrong will go wrong, which also means if there is a chance that you might be misunderstood – you surely will.

What does it mean in the scientific world of preclinical studies? When R&D companies allocate huge budgets to research a new type of treatment or new diagnostic method they want to increase their chances for success as much as possible. To ensure this you need the right biospecimen, but how do you know which is right and which is not?
BIOMEDICA CRO exclusively proposes samples collected in its network of clinical sites and establishes a direct communication line from the customer to the primary investigator who is personally collecting biospecimens.

Why is this important? Your study may have a particular collection protocol or complicated processing. Your scientists may change or add some details during the PO discussion with the supplier or even modify some criteria after sample collection has already started.
The only way to make sure that all necessary details will be strictly followed – is to shorten the way between you and the person who is in charge of human biospecimen collection. You may avoid all possible misunderstandings and secure the quality of your research by ordering samples from the BIOMEDICA CRO – a direct samples supplier. We supply only biospecimens collected through our clinical sites. Our site managers constantly communicate with responsible physicians and make sure you always get what you want.

“Direct communication between the customer & the primary investigator is a key to successful preclinical research,” says Iryna Iurkova, Business Development Director of BIOMEDICA CRO.

Our company may propose to establish virtual training with primary investigators or you may even observe the processing process done in our laboratory – when processing details have a significant impact on the study result.
Do not waste your budget and time on the sources and biospecimen you can never track. Just contact our team and place your project order. BIOMEDICA CRO will do the rest.

Please email us to start our collaboration: office@biomedica-cro.com / LinkedIn.

Feel free to place a request for human biospecimens.

Share this post

Facebook Twitter LinkedIn
All publications
Trusted biospecimens provider as a part of your successful research strategy
Using human blood and urine samples for the development of new multi-cancer early detection methods
  • Biospecimens
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts

Privacy Policy | Terms of use

Linkedin

Site development mamontova design

BIOMEDICA CRO
© 2021 | All rights reserved

View the Inventory

Click on the button "Download the inventory" to review the list of ready-to-ship biospecimens.

Download the Inventory

Iryna Iurkova

Business Development Director

Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.

Serhii Samsoniuk

Chief Executive Officer

Mr. Samsoniuk is a pharmaceutical expert with over 15 years of industry experience. Over the course of his career, he has held key leadership roles at both international and local companies, such as GlaxoSmithKline, B.Braun, and Sona Exim, overseeing strategic marketing, sales, and key account management. Before joining BIOMEDICA CRO team, he led business development efforts in the CCA+ region at Farmak, driven by a commitment to professional ethics and strategic partnership.

Anton Zubov - MD, BIOMEDICA CRO Co-Founder, Board Member

Anton Zubov

MD, BIOMEDICA CRO Co-Founder,
Board Member

Dr. Zubov has over 21 years of experience in the international pharmaceutical markets. He has held numerous leading positions in marketing, management and sales at Schering AG and Bayer Pharmaceuticals. He has made a career internationally with positions in Ukraine, Germany and Central Asia. In 2017, together with Dr. Kupnovitsky, he founded BIOMEDICA CRO and during the first years was its CINO. Dr. Zubov is currently a Marketing & Sales Director of the CIS Region in Farmak and Board Member of BIOMEDICA CRO Supervisory Board.

have any questions?

Send request

Fill out the form and we will contact you shortly

    Name

    E-mail

    Your message


    have any questions?

    Send request

    Please send us a message and we’ll be back to you shortly

      Name

      Company name

      E-mail

      Your message

      Ostap Kupnovitsky - PhD, MD, MBA, BIOMEDICA CRO Co-Founder, Chairman of the Supervisory Board

      Ostap Kupnovitsky

      PhD, MD, MBA,
      BIOMEDICA CRO Co-Founder,
      Chairman of the Supervisory Board

      Dr. Kupnovitsky has a vast experience in the pharmaceutical market. He was the Regional Director of Organon and Serono in Ukraine. In 2003, he became a Co-Founder and Director of Sona-Pharm, the firm that started its activity in Ukraine and has flourished into an international marketing company with its representatives throughout the CIS region. Since 2017, when BIOMEDICA CRO was founded, he has been a distinguished Chairman of its Supervisory Board.